Related Experiment Video
Updated: Feb 19, 2026
07:43
Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
Published on: May 3, 2024
4.5K
Whole-exome analysis in osteosarcoma to identify a personalized therapy
Caterina Chiappetta1, Massimiliano Mancini1, Francesca Lessi2
1UOC of Pathology, Department of Medical-Surgical Sciences and Bio-Technologies, Sapienza University of Rome, Latina, Italy.
Oncotarget
|November 9, 2017
Summary
This study analyzed osteosarcoma (bone cancer) genetics, identifying key mutated genes like KMT2C. These findings may lead to targeted therapies and improved survival for pediatric cancer patients.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Osteosarcoma is the most common pediatric bone cancer.
- Current treatments rely on non-selective chemotherapy, highlighting the need for targeted therapies.
- Patient survival is linked to chemotherapy response and metastasis development.
Purpose of the Study:
- To investigate the genetic underpinnings of osteosarcoma through exomic sequencing.
- To correlate genetic alterations with clinical and pathological features.
- To identify potential molecular targets for personalized osteosarcoma therapy.
Main Methods:
- Exomic sequence analysis of 8 diagnostic osteosarcoma biopsies.
- Identification and analysis of somatic variations across genes.
- Correlation of genetic alterations with patient response to therapy and metastasis.
Main Results:
- Identified 18,275 somatic variations in 8,247 genes.
- Found mutations in KIF1B, NEB, and KMT2C in 87% of samples, with KMT2C showing the most variations.
- Discovered 15 genes with variations exclusively in non-responding, metastatic patients, some linked to carcinogenesis.
Conclusions:
- KMT2C, a histone modifier, is a novel, frequently mutated gene in osteosarcoma.
- Specific gene variations correlate with treatment resistance and metastasis.
- These findings offer potential molecular targets for early diagnosis, new therapeutic strategies, and personalized osteosarcoma treatment.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K